CuraSen Therapeutics Announces $54.5 Million Series A Financing with Industry Veterans at Helm to Develop Drugs Targeting Novel Mechanism for the Treatment of Neurodegenerative Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2yO7qxB
via IFTTT